Stay updated with breaking news from Reproductive Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomarker offers another companion diagnostic option to establish eligibility for FDA-approved drug ELAHERE® SALT LAKE CITY, May 24, 2023 -- Myriad Genetics, Inc. , a leader in genetic testing... | June 11, 2023
24.05.2023 - Biomarker offers another companion diagnostic option to establish eligibility for FDA-approved drug ELAHERE SALT LAKE CITY, May 24, 2023 (GLOBE NEWSWIRE) - Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, ...
Blanca Reyes is passionate about something others might find unusual – greater benefits equity. When Reyes, a Senior Benefits Analyst under the Vice Chancellor - Chief Financial Officer, realized that many of the resources available to staff were cat
:max_bytes(150000):strip_icc()/OPILL-PACK1MOIS-BOX3ALU-Simplifie-3D-V1-3b02efdc92604daebe27e4f3b994f73a.png)
A panel of FDA advisors unanimously recommended that Opill receive FDA approval last week as an over-the-counter (OTC) birth control option. This would be the first OTC birth control option, increasing accessibility to contraceptives.
As a Yale student, Siddiqi has embraced her identity and her heritage in pursuing a growing passion for politics and medicine — and a career in global health.